MedPath

Comparison of the therapeutic effect of injectable pantoprazole and famotidine in patients with epigastric pai

Phase 3
Recruiting
Conditions
epigastric pain.
Pain localized to upper abdomen
R10.1
Registration Number
IRCT20230614058478N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with epigastric pain referred to the emergency department of Khatam Zahedan Hospital in 1401

Exclusion Criteria

- Unwillingness to participate in the study
Pregnancy, patients with unstable vital signs, receiving antacids
Receiving antacid/H2 receptor blockers/PPI within two hours before ED visit, known allergy to study agents
Epigastric pain suspected of MI
Age over 60 and under 18, cholecystitis, suspected dissection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity after drug injection. Timepoint: 0-30-60 Minutes after receiving the medicine. Method of measurement: Assessing pain based on what is visible on the patient's face (VAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath